Skip to content
Biotechnology News, Trends & Expert Insights

Our Latest

November 17, 2026

Also on the bench

  1. BetterLife Pharma Announces Stock Option Grant
  2. BetterLife Pharma Announces New Preclinical Research Highlighting Neuroplasticity-Related Effects of Non-Hallucinogenic BETR-001 at Neuroscience 2026
  3. Senti Bio Announces Reverse Stock Split
  4. Thermosome Closes Exclusive Global Licensing Agreement with Avenor Therapeutics
  5. Mobile Apps for DNA Sequencing Market to Reach $2.4 Billion by 2031
  6. Kraig Biocraft Laboratories CEO Publishes Forbes Technology Council Article on the Future of Bio-Engineered Materials
  7. Zenas BioPharma Launches The Distance Between Platform to Bring Greater Visibility to the Hidden Burden of IgG4-Related Disease
  8. Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026
  9. CancerVax Successfully Kills Cancer Cells in Landmark Test
  10. New AI-Powered Canine DNA Technology Helps Dog Owners Understand Their Dogs' Lifetime Cancer and Heart Disease Risks
  11. IMDx Reports Third Quarter 2026 Results and Provides Corporate Update
  12. Genelux Corporation Reports Third Quarter Financial Results and Provides Business Updates
  13. Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  14. Acrivon Reports Third Quarter 2026 Financial Results and Business Highlights
  15. Insight Molecular Diagnostics Announces Proposed Public Offering
  16. Kyntra Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
  17. ORIC® Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Operational and Rinzimetostat Program Updates
  18. Exicure Announces Filing of Notification of Late Filing on Form 12b-25
  19. Candel Therapeutics (CADL) Faces Investor Scrutiny After Surprise BLA Delay Drives Stock 26% Lower – HBSS
View all Posts112 posts on Biotech News